In polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs), tumor-derived GM-CSF/STAT5 signaling upregulates FATP2, enhancing the arachidonic acid uptake and prostaglandin E2 synthesis that suppress T cell responses. Here, SLC27A2 is linked to neoplasm.